OHSU Sponsored Projects Awards - Fiscal Year 2009 (July 1, June 30, 2009) Department of Medicine

Size: px
Start display at page:

Download "OHSU Sponsored Projects Awards - Fiscal Year 2009 (July 1, June 30, 2009) Department of Medicine"

Transcription

1 OHSU Sponsored Projects Awards - Fiscal Year 2009 (July 1, June 30, 2009) Department of Medicine Division PI Name OGA Project Number Budget Start Date BudgetEndDat e Awarding Agency Project Title Funding Type Activity Type of Arth & Mus & Skin Positive and Negative Regulation of IL-17 in Experimental Arthritis & Rheumatic Diseases Chu, Cong-Qiu GARTH0054B 06/01/09 05/31/10 Diseases Arthritis Federal Research Jun , of Arth & Mus & Skin Positive and Negative Regulation of IL-17 in Experimental Arthritis & Rheumatic Diseases Chu, Cong-Qui GARTH0054A 08/01/08 05/31/09 Diseases Arthritis Federal Research Aug , Arthritis & Rheumatic Diseases Deodhar, Atulya GARTH /23/05 11/22/08 Bristol-Myers Squibb A Phase III Multi-Center, Open Label Study to Evaluate the Efficasy, Tolerability and Safety of Abatacept (BMS in Subjects with Active Rheumatoid Arthritis on Background Non-Biologic DMARDs Who Have An Inadequate Response to Anti-TNF Industry Research Jan-09 5, Month Awarded Total Cost Arthritis & Rheumatic Diseases Deodhar, Atulya GARTH /01/05 10/01/10 Genentech, Inc. A Random, Placebo Contr,D-B,P G, International Study to Evaluate the Safety & Efficacy of Rituximab(MabThera/Rituxan) in combimation w/methotrexate, Compared to Methotrexate Monotherapy in Patients with Active Rheumatoid Arthritis Industry Research Feb-09 7, Arthritis & Rheumatic Diseases Deodhar, Atulya GARTH /01/05 10/01/10 Genentech, Inc. A Random, Placebo Contr,D-B,P G, International Study to Evaluate the Safety & Efficacy of Rituximab(MabThera/Rituxan) in combimation w/methotrexate, Compared to Methotrexate Monotherapy in Patients with Active Rheumatoid Arthritis Industry Research May-09 4, A Randomized, Double-Blind, Placebo Controlled, Parallel- Group, Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of Ocrelizumab in Patients with Arthritis & Rheumatic Diseases Deodhar, Atulya GARTH /19/08 08/31/11 Genentech, Inc. WHO or ISN Class III or IV Nephritis Due to Systemic Lupus Erythematosus Industry Research Aug , A Randomized, Double-Blind, Parallel-Group Study to Evaluate Safety & Efficacy of Tocilizumab Versus Placebo Hoffmann-La Roche, in Combination w/methotrexate in Patients w/moderate to Arthritis & Rheumatic Diseases Deodhar, Atulya GARTH /03/08 11/30/10 Inc. Severe Active Rheumatoid Arthritis Industry Research Sep , Arthritis & Rheumatic Diseases Deodhar, Atulya GARTH0056A 02/01/09 DHHS Indian Health 01/31/10 Service CONTRACT OHSU-Indian Health Services Rheumatology Initiative Federal OSA Feb-09 12, Phase 2, Randomized, MC, PC, PG study to Investigate Safety, Efficacy, Pharmacokinetics & Pharmacodynamics 12Wks of Treatment w/arry in Patients w/active Ankylosing Spondylitis & Inadequate Response to Arthritis & Rheumatic Diseases Deodhar, Atulya GARTH /08/09 05/31/12 Array BioPharma, Inc. Conventional Therapy Industry Research May-09 67, Cardiology Broberg, Craig GCARD0129A 07/01/08 06/30/09 Association, Inc. Heart Failure in Congential Heart Disease: The Role of Myocardial Fibrosis Private Research Oct-08 55, Cardiology Broberg, Craig GCARD0129B 07/01/09 06/30/10 Association, Inc. Heart Failure in Congential Heart Disease: The Role of Myocardial Fibrosis Private Research Jun-09 55, Cardiology Carr, Chad GCARD0121B 01/01/09 Assoc., Pacific 12/31/09 Mountain Affiliate Molecular Imaging for the Non-invasive Assessment of Inflammation and Angiogenesis Private Research Dec-08 48, Cardiology Chadderdon, Scott GCARD0126A 07/01/08 06/30/09 Association, Inc. Assessment of Vascular Imaging and Remodeling with Molecular Imaging in Obese and Insulin Resistant Primates Private Research Jun-09 67,000.00

2 Cardiology Chadderdon, Scott GCARD0126A 07/01/08 06/30/09 Association, Inc. Cardiology Chadderdon, Scott GCARD0126B 07/01/09 06/30/10 Association, Inc. Cardiology Cigarroa, Joaquin GCARD /03/09 04/30/12 Celladon Corporation Cardiology Cigarroa, Joaquin GCARD /03/09 04/30/12 Celladon Corporation M.J. Murdock Cardiology Kaul, Sanjiv GCARD0128A 10/01/08 09/30/09 Charitable Trust Cardiology Kaul, Sanjiv GCARD0131A 12/22/08 07/31/10 CV Therapeutics, Inc. Assessment of Vascular Imaging and Remodeling with Molecular Imaging in Obese and Insulin Resistant Primates Private Research Sep-08 65, Assessment of Vascular Imaging and Remodeling with Molecular Imaging in Obese and Insulin Resistant Primates Private Research Jun , Phase 1 Trial of Intracoronary Administration of MYDICAR (AAVI/SERCA2a) in Subjets w/heart Failure DIvided into 2 Stages: Stage 1 OL, Sequential Dose-Escalation Cohorts Followed in Stage 2 by Randomized, DB, PC, Parallel Cohorts Industry Research Apr , Assessment of Antibodies to Adeno-Associated Vector Number CELL-002 Industry Research Apr-09 23, Construction of High-Speed Digital Camera for Microbubble-mediated Therapeutic Ultrasound in Heart Disease Private OSA Oct-08 50, An Open-Label, Parallel Group, Exploratory Study to Evaluate the Efficacy and Safety of 400mg Regadenosen Bolus for Pharmacological Stress Echocardiography Industry Research Jan , Cardiology Kaul, Sanjiv GCARD0132A 12/02/08 12/01/09 CV Therapeutics, Inc. Regadenoson and Myocardial Contrast Echocardiography Industry Research Feb-09 78, Cardiology Kim, Antony GCARD0138A 07/01/09 05/31/10 Blood Inst The Evolution of Endocardial Thrombosis in Heart Failure Federal Research Jun , Contrast Ultrasound Assessment of Microvascular Cardiology Lindner, Jonathan GCARD0127A 09/25/08 07/31/09 Kid Diseases Function in Insulin Resistant Non-Human Primates Federal Research Oct , Cardiology Lindner, Jonathan GCARD0130A 11/18/08 OHSU Heart Rsch 11/18/09 Ctr Intravital Microscopy Laboratory Private OSA Dec-08 17, Cardiology Lindner, Jonathan GCARD0137A 06/01/09 05/31/10 Blood Inst Molecular Imaging of Infalmmation in Atherosclerosis Federal Research Jun , Cardiology Maslen, Cheryl GCARD0124A 06/01/08 Thru Oregon Biomedical Engineering Institute, Inc. fr U.S. Army Medical Research and Materiel 05/31/09 Command Phase X: Battlefield Tissue Replacement and Repair Using Tropoelastin and Chitosan Biomaterials Federal Research Aug-08 32, Thru RTI International Cardiology Maslen, Cheryl GEDCN0194A 10/01/06 fr 09/30/09 Blood Inst National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions - Data Coordinating Center Federal Research Sep , Thru RTI International Cardiology Maslen, Cheryl GEDCN0194A 10/01/06 fr 09/29/10 Blood Inst National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions - Data Coordinating Center Federal Research Jun-09 2, Cardiology Maslen, Cheryl GEDCN0197B 02/01/08 Thru Johns Hopkins Univ. fr DHHS NIH Natl 01/31/09 Blood Inst Genetic basis for congenital heart disease Federal Research Aug , Cardiology Maslen, Cheryl GEDCN0197B 02/01/08 Thru Johns Hopkins Univ. fr DHHS NIH Natl 01/31/10 Blood Inst Genetic basis for congenital heart disease Federal Research May , Genzyme Cardiology Mays, Maureen GCARD /07/09 05/31/12 Corporation A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS ad Add On Therapy in Heterozygous Familial Hypercholesterolemic Subjects w/coronary Artery Disease (CAD) Industry Research May-09 57,158.00

3 Cardiology Raitt, Merritt GCARD0087A 07/01/04 Thru Portland VA Rsch Fdn fr Atlanta Research & Education 12/31/09 Foundation, Inc. Cardiology Shapiro, Michael GCARD /26/09 02/29/12 GE Healthcare Inc Cardiology Wei, Kevin GCARD /14/08 08/31/11 GE Healthcare Inc Cardiology Wei, Kevin GCARD /14/08 08/31/11 GE Healthcare Inc Antiarrhythmic Effects of Spironolactone in Patients with ICDs Private Research Mar-09 5, A Prospective, Multi-Center, Registry Study for Clinical OUtcome in Subjects Undergoing Coronary Computed Tomography Angiography (CCTA) Examination Industry Research Mar , An Observational Study of the Occurrence of Serious Adverse Reactions among Patients Who Receive Optison in Routine Medical Practice (Optison Registry Study) Industry Research Aug-08 54, An Observational Study of the Occurrence of Serious Adverse Reactions among Patients Who Receive Optison in Routine Medical Practice (Optison Registry Study) Industry Research Jan , Cardiology Wei, Kevin GCARD /14/08 08/31/11 GE Healthcare Inc Cardiology Zhou, Zhengfeng GCARD0105D 06/01/09 05/31/10 Blood Inst Cardiology Zhou, Zhengfeng GCARD0122B 01/01/09 12/31/09 Association, Inc. An Observational Study of the Occurrence of Serious Adverse Reactions among Patients Who Receive Optison in Routine Medical Practice (Optison Registry Study) Industry Research Oct-08 40, Pathogenesis of herg Mutations in Human Long QT Syndrome Federal Research May , Nonsense-mediated mrna decay in arrhythmogenic right ventricular dysplasia Private Research Dec , Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research Aug-08 4, Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research Apr-09 3, Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research Jul-08 4, A random open-lbl Multictr t to Examine the effects of Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research Dec Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research Oct Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research May-09 2, Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research Jan-09 58, Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 06/30/09 Pharmaceuticals, Inc. antidiabetic meds Industry Research Mar-09 23,232.00

4 Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /15/06 05/31/10 Pharmaceuticals, Inc. antidiabetic meds Industry Research Jun-09 3, Medtronic MiniMed, Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /17/07 07/17/10 Inc. Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN0216A 08/01/08 07/31/09 Meyer Memorial Trust Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN /08/09 MannKind 05/31/12 Corporation California, San Francisco fr DHHS NIH Natl Inst of Allergy & Infectious Endo/Diab/Clin Nutrition Ahmann, Andrew GEDCN0228A 03/01/09 12/31/12 Disease A Prospective, R, Two-Arm Stdy to Compare the Efficacy of the Medtronic Minimed Paradign Real-Time System V. multiple Daily Injection (MDI) In Subjects W/ Type 1 Diabetes Mellitus Naive to Insulin Pump Therapy Industry Research Mar-09 33, Harold Schnitzer Diabetes Health Center Rural Outreach Proposal Private Research Sep , Ph 3, MC, OL, Randomized, CT Evaluating Efficacy & Safety of Technosphere Insulin Inhalation Powder in Combination w/lantus Vs. Humalog in Combination w/lantus in Subjects w/type 1 Diabetes Mellitus Over a 16-Wk Treatment Period Industry Research May , A Phase 1 Trial of Proleukin and Rapamune in Recentonset Type 1 Diabetes Mellitus Federal Research Jun , of Arth & Mus & Skin Endo/Diab/Clin Nutrition Bliziotes, Matthew GEDCN0166D 09/01/08 08/31/09 Diseases The Function of Neurotransmitters in Bone Biology Federal Research Aug , Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy & Safety of ISIS as Add On Isis Pharmaceuticals, Therapy in Heterozygous Familial Hypercholesterolemic Endo/Diab/Clin Nutrition Connor, William GEDCN /19/08 09/30/11 Inc Subjects w/ Coronary Artery Disease (CAD) Industry Research Sep-08 56, Phase III, Open-Label, Multicenter International Study to Indevus Evaluate Efficacy & Safety of Octreotide Implant vs. Endo/Diab/Clin Nutrition Cook, David GEDCN /16/08 12/31/11 Pharmaceuticals, Inc. Sandostatin LAR depot in Patients with Acromegaly Industry Research Dec , Somatuline Depot (Ianreotide) Injection for Acromegaly Endo/Diab/Clin Nutrition Cook, David GEDCN /02/09 04/30/14 Tercica, Inc. (SODA): A Post-marketing Obersvational Study Industry Research Apr , Endo/Diab/Clin Nutrition Fan, Wei GCSWR0025B 06/01/09 05/31/10 Kid Diseases Regulation of Thermogenesis by the Melanocortin System Federal Research Jun , Novartis A multicenter, randomized, blinded study to assess safety Pharmaceuticals and efficacy of pasireotide LAR vs octreotide LAR in Endo/Diab/Clin Nutrition Fleseriu, Maria GEDCN /10/08 11/20/10 Corporation patients t with active acromegaly Industry Research Nov-08 36, of Arth & Mus & Skin Endo/Diab/Clin Nutrition Klein, Robert GEDCN0165D 09/01/08 08/31/09 Diseases Genetic Analysis of Bone Strength in Mice Federal Research Aug , Ctr Endo/Diab/Clin Nutrition Klopfenstein, Bethany GEDCN0186C 08/01/08 07/31/09 for Rsch Resources Cortisol Regulation in PCOS Federal Research Sep , Endo/Diab/Clin Nutrition Klopfenstein, Bethany GEDCN /04/09 01/31/11 Sanofi-Aventis US Randomized, db, pc, 2-arm parallel-group, multicenter study w/a 24-week main treatment period & extension assessing efficacy & safety of AVE0010 in patients with Type 2 diabetes insufficiently controlled with basal insulin Industry Research Feb , Endo/Diab/Clin Nutrition Madison, Dana GEDCN0160D 07/01/08 06/30/09 Cancer Inst Transcriptional Repression by CtBP at the p21 Promoter Federal Research Jul , Endo/Diab/Clin Nutrition Madison, Dana GEDCN0160E 07/01/09 06/30/10 Cancer Inst Transcriptional Repression by CtBP at the p21 Promoter Federal Research Jun , California, Davis fr of Arth & Mus & Skin Endo/Diab/Clin Nutrition Marshall, Lynn GEDCN0155D 08/01/08 07/31/09 Diseases The Epidemiology and Genetics of Hip OA in Elderly Man Federal Research Sep-08 35, Endo/Diab/Clin Nutrition Marshall, Lynn GEDCN0211B 09/01/08 Pittsburgh fr DHHS NIH Natl Inst of Arth & Mus & Skin 08/31/09 Diseases PITT-MCRC for Rheumatic and Musculoskeletal Diseases Federal Research Jan-09 74,246.00

5 Thru Johns Hopkins Endo/Diab/Clin Nutrition Marshall, Lynn GEDCN0215A 06/15/08 Univ. fr DHHS NIH 05/31/09 Natl Cancer Inst Sleep Apnea and Longitudinal Chanes in Glycemia and Inflammation in Older Men Federal Research Sep , Thru Brigham and Women's Hospital, Inc. fr The Interplay between Sleep, Melatonin, and Mortality in Endo/Diab/Clin Nutrition Marshall, Lynn GEDCN0220A 08/01/08 06/30/09 Inst on Aging Older Men Federal Research Feb-09 91, of Arth & Mus & Skin Endo/Diab/Clin Nutrition Orwoll, Eric GEDCN0181C 08/01/08 07/31/09 Diseases Osteoporotic Fractures in Men (MrOS) Renewal- Portland Federal Research Aug , O.N. Diagnostics, Endo/Diab/Clin Nutrition Orwoll, Eric GEDCN0222A 01/01/09 06/30/09 LLC Osteoporotic Fractures in Men (MrOS): Study Data Industry OSA Mar-09 44, Endo/Diab/Clin Nutrition Riddle, Matthew GEDCN0117A2 10/01/03 Washington fr DHHS NIH Natl Heart, Lung, 10/31/09 and Blood Inst ACCORD Federal Research Mar-09 17, Endo/Diab/Clin Nutrition Riddle, Matthew GEDCN0117C1 11/01/07 Washington fr DHHS NIH Natl Heart, Lung, 10/31/08 and Blood Inst ACCORD Federal Research Jul , Endo/Diab/Clin Nutrition Samuels, Mary GEDCN0214A 08/05/08 06/30/09 Kid Diseases Neurocognitive and Metabolic Effects of Mild Hypothyroidism Federal Research Aug , Endo/Diab/Clin Nutrition Samuels, Mary GEDCN0214B 07/01/09 06/30/10 Kid Diseases Neurocognitive and Metabolic Effects of Mild Hypothyroidism Federal Research Jun , Endo/Diab/Clin Nutrition Ward, William GCSEN0034B1 01/01/09 12/31/09 Kid Diseases Noninvasive BLood Glucose Monitoring Using Otoacustic Emmisions Federal Research Apr-09 4, Thru Legacy Emanuel A Comparison of Two Sensor-Augmented Glycemic Endo/Diab/Clin Nutrition Ward, William GEDCN0218A 10/01/08 Hosp & Hlth Ctr fr Juvenile Diabetes 01/31/10 Rsch Fnd InterNatl Control Systems in Persons w/type 1 or Insulin-treated Type 2 Diabetes Mellitus: Subcutaneous (SC) Insulin & Glucagon Infusion vs. Insulin Only Infusion Private Research Nov , Endo/Diab/Clin Nutrition Yuen, Kevin GEDCN /10/08 12/31/10 Genentech, Inc. Effects of a Fixed Low Dose Growth Hormone (GH) Therapy on Insulin Sensitivity (Si), Metabolic Profile, Muscle IGF-I & Insulin Responsiveness & Signaling, Intramyocellular Lipids (IMCL) & Cortisol Metabolism in Obese Women w/ Polycystic... Industry Research Oct-08 10, Endo/Diab/Clin Nutrition Yuen, Kevin GEDCN /10/08 12/31/10 Genentech, Inc. Effects of a Fixed Low Dose Growth Hormone (GH) Therapy on Insulin Sensitivity (Si), Metabolic Profile, Muscle IGF-I & Insulin Responsiveness & Signaling, Intramyocellular Lipids (IMCL) & Cortisol Metabolism in Obese Women w/ Polycystic... Industry Research Jul , Gastroenterology & Hepatology Collins, Judith GGAST /16/04 12/31/10 Centocor, Inc Remicade Safety Under Long Term Study in Ulcerative Colitis (RESULTS-UC) Industry Research May Gastroenterology & Hepatology Collins, Judith GGAST /16/04 12/31/10 Centocor, Inc Remicade Safety Under Long Term Study in Ulcerative Colitis (RESULTS-UC) Industry Research Feb-09 1, Gastroenterology & Hepatology Collins, Judith GGAST /16/04 12/31/10 Centocor, Inc Remicade Safety Under Long Term Study in Ulcerative Colitis (RESULTS-UC) Industry Research Jul Gastroenterology & Hepatology Collins, Judith GGAST /16/04 12/31/10 Centocor, Inc Remicade Safety Under Long Term Study in Ulcerative Colitis (RESULTS-UC) Industry Research Mar A Phase 2/3 Multicenter, Randomized, Placebo-Controlled Study to Evaluate Safety & Efficacy of Gollmumab Induction Therapy, Administered Sucutaneously, in Subjects w/moderately to Severely Active Ulcerative Gastroenterology & Hepatology Collins, Judith GGAST /02/08 08/31/09 Centocor, Inc Colitis Industry Research Jul-08 71, Gastroenterology & Hepatology Collins, Judith GGAST /02/08 08/31/09 Centocor, Inc A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety & Efficacy of Gollmumab Maintenance Therapy, Administred Subcutaneously, In Subjects w/ Moderately to Severely Active Ulcerative Colitis Industry Research Jul ,847.00

6 Gastroenterology & Hepatology Eisen, Glenn GGAST /27/08 02/28/11 Given Imaging, Inc. Evaluation of PillCam(TM) ESO 2 in Patients with Suspected Esophageal Pathologies Industry Research Jul-08 2, Gastroenterology & Hepatology Eisen, Glenn GGAST /15/08 12/31/11 BARRx, Inc. HALO Patient Registry: Ablation of Barrett's Esophagus Industry Research Dec-08 9, Gastroenterology & Hepatology Lieberman, David GCNCR0173B 09/01/08 08/31/09 Cancer Inst Screening for colorectal cancer in an Asian Community Center Federal Research Sep , Gastroenterology & Hepatology Lieberman, David GGAST0042E 09/01/08 08/31/09 Kid Diseases Clinical Outcomes Research: An Endoscopic Data Base Federal Research Sep , Gastroenterology & Hepatology Lieberman, David GGAST0067C 07/01/08 Clinical Outcomes 06/30/09 Research Initiative Clinical Outcomes Research Initiatives, 501 (c)3 (CORIb) Private Research Aug , Gastroenterology & Hepatology Lieberman, David GGAST0076B 12/01/08 11/30/09 Cancer Inst Colonoscopy in Rural Oregon Practice (CROP) Federal Research Mar-09 13, Gastroenterology & Hepatology Lieberman, David GGAST0076B 12/01/08 11/30/09 Cancer Inst Colonoscopy in Rural Oregon Practice (CROP) Federal Research Dec , Gastroenterology & Hepatology Lieberman, David GGAST0091A 04/14/08 U.S. Dept of Veterans 09/28/08 Affairs VA IPA for Jeffrey Lucas Williams Federal Research Aug-08 24, Gastroenterology & Hepatology Lieberman, David GGAST0092A 04/14/08 U.S. Dept of Veterans 09/28/08 Affairs VA IPA for Anke Brandstater Federal Research Aug-08 23, A Phase III randomized, double-blind, placebo-controlled Bayer HealthCare study of sorafenib as adjuvant treatment for hepatocellular Gastroenterology & Hepatology Schwartz, Jonathan GGAST /09/09 02/29/12 Pharmaceuticals, Inc. carcinoma after surgical resection or local ablation Industry Research Feb-09 82, Bayer HealthCare Global Investigation of Therapeutic Decision in Gastroenterology & Hepatology Schwartz, Jonathan GGAST /15/09 06/30/14 Pharmaceuticals, Inc. Hepatocellular Carninoma and of its Treatment (GIDEON) Industry Research Jun-09 45, Thru Oregon Dept of Human Svcs, Hlth Gastroenterology & Hepatology Zaman, Atif GGAST0058D 07/01/08 Svcs Div fr DHHS CDCP Natl Ctr for 06/30/09 Infectious Disease Chronic Liver Disease Surveillance Follow-Up Study (GGAST0058A) and Multnomah County Hepatitis C Registry Study (MCHRS) (GGAST0058A1) Federal Research Aug-08 16, Gastroenterology & Hepatology Zaman, Atif GGAST0058D1 07/01/08 Thru Oregon Dept of Human Svcs, Hlth Svcs Div fr DHHS CDCP Natl Ctr for 06/30/09 Infectious Disease Chronic Liver Disease Surveillance Follow-Up Study (GGAST0058A) and Multnomah County Hepatitis C Registry Study (MCHRS) (GGAST0058A1) Federal Research Aug-08 22, Gastroenterology t & Hepatology Zaman, Atif GGAST0061D1 09/01/08 Texas, Southwestern Medical Ctr at Dallas fr 08/31/09 Kid Diseases A Multi-Center t Trial to Study Acute Liver Failure Federal Research May-09 19, Gastroenterology & Hepatology Zaman, Atif GGAST /06/08 Zymogenetics, Inc. 02/28/11 (ZGEN) A Phase I Study to Assess the Safety and Antiviral Activity of PEG-rIL-29 Administered as a Single Agent and in Combination w/ Ribavirin in Subjects w/ Treatment- Relapsed Chronic Hepatitis C Virus Infection Industry Research Jun-09 6, Zymogenetics, Inc. Gastroenterology & Hepatology Zaman, Atif GGAST /06/08 02/28/11 (ZGEN) Zymogenetics, Inc. Gastroenterology & Hepatology Zaman, Atif GGAST /06/08 02/28/11 (ZGEN) Roche Laboratories, Gastroenterology & Hepatology Zaman, Atif GGAST /09/08 12/31/10 Inc. A Phase I Study to Assess the Safety and Antiviral Activity of PEG-rIL-29 Administered as a Single Agent and in Combination w/ Ribavirin in Subjects w/ Treatment- Relapsed Chronic Hepatitis C Virus Infection Industry Research Mar-09 34, A Phase I Study to Assess the Safety and Antiviral Activity of PEG-rIL-29 Administered as a Single Agent and in Combination w/ Ribavirin in Subjects w/ Treatment- Relapsed Chronic Hepatitis C Virus Infection Industry Research Feb-09 21, Prospective Observational Study on Predictors of Early- On Treatment Response and Sustained Virological Response in a Cohort of Treatment Naive HCV-Infected Patients Treated with Pegylated Interferons Industry Research Feb-09 60, Gastroenterology & Hepatology Zaman, Atif GGAST /28/08 08/31/11 GlaxoSmithKline Randomised, DB, PC, MC Study to Evaluate Safety & Efficacy of Eltrombopag to Reduce Need for Platelet Transfusion in Thrombocytopenic Subjects w/chronic Liver Disease Undergoing Elective Invasive Procedures. Industry Research Sep ,538.10

7 A Rand. Study of Stopping Tx at 24 Weeks or Continuing Tx to 48 Weeks in Tx-Naive Subjects with Genotype 1 Chronic Hepatitis C who Achieve an Extended Rapid Viral Vertex Response (ervr) While Receiving Telaprevir, Gastroenterology & Hepatology Zaman, Atif GGAST /25/08 11/30/11 Pharmaceuticals, Inc. Peginterferon Alfa... Industry Research Nov , Roche Laboratories, Gastroenterology & Hepatology Zaman, Atif GGAST /10/09 02/29/12 Inc. Hoffmann-La Roche, Gastroenterology & Hepatology Zaman, Atif GGAST /12/09 06/30/12 Inc. Medical Research General Internal Medicine Gregg, Jessica GINTR0047A 09/01/08 08/31/09 Foundation of Oregon MC, randomized, ol, controlled study of effect of treatment w/once wkly Pegasys + daily Copegus w/ or w/out concomitant pioglitazone(actos) on early viral kinetics in treatment-naive pts w/chronic hepatitis C & insulin resistance Industry Research Feb , An open-label, mc protocol providing pegylated interferon alfa-2a (PEGASYS) as monotherapy or in combination w/ribavirin (COPEGUS) for patients w/chronic hepatitis C who have participated in previous Roche or Roche protocols Industry Research Jun-09 27, Surveying Health Beliefs, Acculturation, and Pap Smear Use among Latinos from Mexico Private Research Oct-08 40, Thru Immigrant and Refugee Community Organization fr DHHS Beliefs about the Pap smear and cervical cnacer General Internal Medicine Gregg, Jessica GINTR0051A 04/10/09 11/30/09 NIH Natl Cancer Inst screening among Vietnamese women Federal Research Jun-09 5, General Internal Medicine Haney, Elizabeth GINTR0035D 04/01/09 of Arth & Mus & Skin 03/31/10 Diseases Clinical Implication of Serotonin in Bone Federal Research Mar , General Internal Medicine Haney, Elizabeth GINTR0048A 07/01/08 Association of Specialty Professors 06/30/09 (ASP) Bone Turnover and Bone Loss Among Older SSRI Users Private Research Oct-08 37, General Internal Medicine Haney, Elizabeth GINTR0048B 07/01/09 Association of Specialty Professors 06/30/10 (ASP) Bone Turnover and Bone Loss Among Older SSRI Users Private Research Jun-09 3, General Internal Medicine Haney, Elizabeth GINTR0048B 07/01/09 Association of Specialty Professors 06/30/10 (ASP) Bone Turnover and Bone Loss Among Older SSRI Users Private Research Jun-09 37, General Internal Medicine Korthuis, Philip GINTR0027E 09/01/08 DHHS HRSA 08/31/09 HIV/AIDS Bureau Special Projects of National Significance Federal OSA Aug , General Internal Medicine i Korthuis, Philip GINTR0037C 10/01/08 Thru Johns Hopkins Univ. fr DHHS Agency for Hlthcare 09/26/09 Rsch and Quality HIV Research Network Federal Research Nov-08 80, General Internal Medicine Korthuis, Philip GINTR0037C 10/01/08 Thru Johns Hopkins Univ. fr DHHS Agency for Hlthcare 09/26/09 Rsch and Quality HIV Research Network Federal Research Mar-09 74, General Internal Medicine Korthuis, Philip GINTR0041C 07/01/09 06/30/10 on Drug Abuse Quality Outcomes for Patients with Drug Abuse and HIV Federal Research Jun , General Internal Medicine Korthuis, Philip GINTR0049A 09/01/08 Thru Multnomah County Hlth Dept fr DHHS Hlth Resources and Svcs 08/31/09 Admin SPNS IT Capacity Building Federal OSA Dec-08 18, General Internal Medicine Nicolaidis, Christina GINTR0028D 01/01/09 12/31/09 of Mental Hlth Developing an Abuse-Sensitive Depression Care Model Federal Research Dec , General Internal Medicine Nicolaidis, Christina GINTR0046B 06/01/09 05/31/10 of Mental Hlth CBPR to Improve Depression Care for African-American Domestic Violence Survivors Federal Research Jun , General Internal Medicine O'Hearn, Mary GINTR0050A 03/01/09 Thru Multnomah County Hlth Dept fr DHHS HIV/AIDS 02/28/10 Bureau Ryan White CARE Act Federal OSA Mar , Health Prom & Sports Medicine Goldberg, Linn GHPSM0010D 03/01/08 Thru George Washington Univ. fr 02/28/09 Kid Diseases Prevention of Type 2 Diabetes in Adolescents Federal Research Aug-08 2,904,369.00

8 Health Prom & Sports Medicine Goldberg, Linn GHPSM0010E 03/01/09 Thru George Washington Univ. fr 02/28/10 Kid Diseases Prevention of Type 2 Diabetes in Adolescents Federal Research Jun-09 1,100, Health Prom & Sports Medicine Goldberg, Linn GHPSM0014A 03/01/07 08/31/09 NFL Charities Youth Football Fund Private OSA Jan-09 1,294, Health Prom & Sports Medicine Goldberg, Linn GHPSM0016A 06/01/09 05/31/10 Hydra Dx Assessment of Hydration Stutus by the new HydraDX Field Testing Method Industry OSA Jun-09 55, Health Prom & Sports Medicine Stadler, Diane GEDCN0152D 07/01/08 Thru Kaiser Fnd Hospitals Ctr for Hlth Rsch fr DHHS NIH Natl Ctr for 06/30/09 Complementary & Al Metabolic Risks of Low and High Carbohydrate Diets Federal Research Nov , Hematology & Medical Oncology Agarwal, Anupriya GHEMA0197A 10/01/08 Lady Tata Memorial 09/30/09 Trust Does p27 Act as a Tumor Suppressor or an Oncogene in Chronic Myeloid Leukemia? Private Research Nov-08 44, Hematology & Medical Oncology Alumkal, Joshi GHEMA0176D 07/01/09 Flight Attendant Medical Research 06/30/10 Institute Molecular Changes and Prostate Cancer Outcomes Private Research Jun , Hematology & Medical Oncology Alumkal, Joshi GHEMA0202A 02/01/09 Thru Fred Hutchinson Cancer Rsch Ctr fr 08/31/09 Cancer Inst Elucidation of Novel Mechanisms of Sulforaphane Chemoprevention in a Murine Model of Prostate Cancer Federal Research Mar-09 50, Thru Cancer Therapy Hematology & Medical Oncology Beer, Tomasz GHEMA0041A 01/01/99 Rsch Fnd fr DHHS 12/31/08 NIH Natl Cancer Inst Urologic Cancer Outreach Program (UCOP) of the Southwest Oncology Group, OHSU Federal OSA Oct Thru Cancer Therapy Hematology & Medical Oncology Beer, Tomasz GHEMA0041A 01/01/99 Rsch Fnd fr DHHS 12/31/08 NIH Natl Cancer Inst Urologic Cancer Outreach Program (UCOP) of the Southwest Oncology Group, OHSU Federal OSA Sep Thru Cancer Therapy Hematology & Medical Oncology Beer, Tomasz GHEMA0041A 01/01/99 Rsch Fnd fr DHHS 12/31/08 NIH Natl Cancer Inst Urologic Cancer Outreach Program (UCOP) of the Southwest Oncology Group, OHSU Federal OSA Sep-08 4, Thru Cancer Therapy Hematology & Medical Oncology Beer, Tomasz GHEMA0041A 01/01/99 Rsch Fnd fr DHHS 12/31/09 NIH Natl Cancer Inst Urologic Cancer Outreach Program (UCOP) of the Southwest Oncology Group, OHSU Federal OSA Dec Thru Cancer Therapy Rsch Fnd fr DHHS Urologic Cancer Outreach Program (UCOP) of the Hematology & Medical Oncology Beer, Tomasz GHEMA0041A 01/01/99 12/31/08 NIH Natl Cancer Inst Southwest Oncology Group, OHSU Federal OSA Aug Hematology & Medical Oncology Beer, Tomasz GHEMA0165D 04/01/09 03/31/10 Cancer Inst Resistance and Response Mechanisms to Prostate Cancer Therapy Federal Research Mar , Hematology & Medical Oncology Deininger, Michael GHEMA0157D 09/01/08 08/31/09 Blood Inst Biology of Imatinib-Resistant Mutants of BCR-ABL Federal Research Sep , Hematology & Medical Oncology Deininger, Michael GHEMA0192B 07/01/09 06/30/10 Lymphoma Society Disease Persistence in Chronic Myeloid Leukemia Patients on Imatinib Therapy Private Research Jun , Hematology & Medical Oncology Deininger, Michael GHEMA0199A 11/14/08 Genzyme 11/13/09 Corporation The use of AMD3100 to eliminate persistent Chronic Myeloid Leukemia Cells Industry Research Feb-09 94, Hematology & Medical Oncology Deininger, Michael GHEMA0200A 04/01/09 Ctr 03/31/10 for Rsch Resources IVIS Spectrum Biophotonics Instrument Federal OSA Mar , Hematology & Medical Oncology Deininger, Michael GHEMA0201A 07/31/08 ARIAD 10/15/10 Pharmaceuticals, Inc AP Clinical Trial: Pharmacodynamic Studies Industry OSA Mar-09 45, Hematology & Medical Oncology Druker, Brian GHEMA0144E 05/01/09 04/30/10 Cancer Inst Chronic Myelogenous Leukemia and Bcr-Abl Substrates Federal Research Apr , Hematology & Medical Oncology Druker, Brian GHEMA0151D1 10/01/08 09/30/09 Lymphoma Society Specialized Center of Research in Myeloid Leukemias Private Research Sep , Hematology & Medical Oncology Druker, Brian GHEMA0151D3 10/01/08 09/30/09 Lymphoma Society Specialized Center of Research in Myeloid Leukemias Private Research Sep , Hematology & Medical Oncology Druker, Brian GHEMA0151D4 10/01/08 09/30/09 Lymphoma Society Specialized Center of Research in Myeloid Leukemias Private Research Sep , Hematology & Medical Oncology Druker, Brian GHEMA0151D5 10/01/08 09/30/09 Lymphoma Society Specialized Center of Research in Myeloid Leukemias Private Research Sep-08 90,000.00

9 Hematology & Medical Oncology Druker, Brian GHEMA0151D6 10/01/08 09/30/09 Lymphoma Society Specialized Center of Research in Myeloid Leukemias Private Research Sep-08 90, Hematology & Medical Oncology Druker, Brian GHEMA0151D7 10/01/08 09/30/09 Lymphoma Society Specialized Center of Research in Myeloid Leukemias Private Research Sep-08 90, Hematology & Medical Oncology Fleischman, Angela GHEMA0203A 07/01/09 06/30/10 Amgen, Inc. Identification of the Hematopoietic Progenitor Population Responsible for Initiation of JAK2V617F Mediated Myeloproliferative Neoplasm Industry Research Jun-09 40, Hematology & Medical Oncology Fleming, William GHEMA0191B 07/01/09 06/30/10 Blood Inst Training Program in Molecular Hematology Federal Research Jun , Hematology & Medical Oncology Fleming, William GHEMA0196A 08/15/08 07/31/09 Blood Inst Functional Interactions Between Hematopoietic Progenitors and Enothelium Federal Research Aug , Hematology & Medical Oncology Fleming, William GHEMA0196BST 06/08/09 08/31/10 Blood Inst Functional Interactions Between Hematopoietic Progenitors and Enothelium Federal Research Jun-09 9, Hematology & Medical Oncology Fromme, Erik GINTR0031E 06/01/09 05/31/10 Cancer Inst Systematic Approaches to Supportive Care in Prostate CA Federal Research Jun , Hematology & Medical Oncology Goldman, Devorah GHEMA0195A 08/21/08 of Child Hlth & 07/31/09 Human Dvlp BMP4 regulation of hematopoietic stem cells in vivo Federal Research Aug-08 63, Hayes-Lattin, Livestrong Young Adult Alliance Retrospective Analysis of Hematology & Medical Oncology Brandon GHEMA0204A 01/01/09 12/31/09 Lance Armstrong Fnd Germ Cell Tumor Data Private Research Jun-09 43, Thru Case Western Reserve University fr Hematology & Medical Oncology Maziarz, Richard GHEMA0172C 08/01/08 07/31/09 Blood Inst NHLBI Blood and Bone Marrow Transplant Clinical Research Network Federal Research Apr-09 25, Hematology & Medical Oncology Maziarz, Richard GHEMA0188A 01/01/08 12/31/08 Athersys, Inc. Effects of Multipotent Adult Progenitor Cells (MAPC) on Immune Function (Safety) Industry Research Oct-08 58, Thru National Institute of Infectious Diseases fr The Hematology & Medical Oncology Maziarz, Richard GHEMA0198A 07/01/08 Japan Health 03/31/09 Sciences Foundation Analysis of Hematologic Diseases Associated with Stem Cell Niche and its Application for Regenerative Medicine Private Research Dec-08 42, Thru National Institute of Infectious Diseases fr The Japan Health Analysis of Hematologic Diseases Associated with Stem Hematology & Medical Oncology Maziarz, Richard GHEMA0198A 07/01/08 03/31/09 Sciences Foundation Cell Niche and its Application for Regenerative Medicine Private Research May-09 3, Hematology & Medical Oncology Meyers, Gabrielle GHEMA0139D 07/01/08 Ctr 06/30/09 for Rsch Resources Study of Clonal Dominance in Hematopoiesis in PNH Federal Research Jul , Hematology & Medical Oncology Taylor, Jason GHEMA0194A 07/01/08 06/30/09 Disease Foamy Virus Vectors for Gene Therapy for HIV Infection Federal Instruction Aug , Hematology & Medical Oncology Taylor, Jason GHEMA0194A 07/01/08 06/30/09 Disease Foamy Virus Vectors for Gene Therapy for HIV Infection Federal Instruction Jan-09 33, Hematology & Medical Oncology Taylor, Jason GHEMA0194B 07/01/09 06/30/10 Disease Foamy Virus Vectors for Gene Therapy for HIV Infection Federal Instruction Jun , California Community Target Identification for Therapeutic Intervention in Hematology & Medical Oncology Tyner, Jeffrey GHEMA0184B 11/01/08 10/31/09 Foundation Pediatric Acute Lymphoblastic Leukemia Private Research Dec , Hospital Medicine Englander, Honora GINTR0052A 07/01/09 06/30/10 N. L. Tartar Trust Workforce in Crisis: Exploring Well-Being and Burnout amongst Medical Students in East Africa using "Art of Medcine" Case Discussions Private Research Jun-09 2, Infectious Diseases Chou, Sunwen GINFD0034A 02/01/09 01/31/10 Disease Antiviral Drug Resistance in Human Cytomegalovirus Federal Research Feb ,500.00

10 Infectious Diseases Forrest, Graeme GINFD /13/09 03/31/12 ADMA Biologics Multicenter, double-blind, randomized, placebo-controlled, dose-ranging trial evaluating safety & efficacy of RI-001 in medically immunosuppressed Respiratory Syncytial Virus infected patients at risk of lower tract RSV illness Industry Research Mar-09 37, Thru Multnomah County Hlth Dept fr DHHS HRSA Infectious Diseases Lager-Mesulam, Julia GINFD0015E 03/01/09 02/28/10 HIV/AIDS Bureau Partnership Project HIV Medical Case Management Federal OSA Mar , Infectious Diseases Lager-Mesulam, Julia GINFD0015E1 03/01/09 Thru Multnomah County Hlth Dept fr DHHS HRSA 02/28/10 HIV/AIDS Bureau Partnership Project HIV Medical Case Management Federal OSA Mar-09 20, Infectious Diseases Lager-Mesulam, Julia GINFD0017D 07/01/08 Thru Oregon Dept of Human Svcs, Hlth Svcs Div fr DHHS 06/30/09 CDCP Partnership Project-Prevention Case Manageement Program Federal OSA Oct-08 8, Infectious Diseases Lager-Mesulam, Julia GINFD0017E 07/01/09 Thru Oregon Dept of Human Svcs, Hlth Svcs Div fr DHHS 06/30/10 CDCP Partnership Project-Prevention Case Manageement Program Federal Research Jun , Infectious Diseases Lager-Mesulam, Julia GINFD0027B 08/01/08 Thru Multnomah County Hlth Dept fr DHHS HRSA 07/31/09 HIV/AIDS Bureau Minority AIDS Intiative Case Management Services Fundsmendical case mangement services for high-acuity Black/African American Federal OSA Aug-08 51, Definition of Human Immunodominant CD8 Antigens in Infectious Diseases Nyendak, Melissa GINFD0036A 07/01/08 06/30/09 N. L. Tartar Trust Tuberculosis Private Research Jun-09 2, Infectious Diseases Strasfeld, Lynne GINFD /30/08 05/31/11 Pfizer, Inc. A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone when Used for Primary Therapy of Proven or Probable Invasive Aspergillosis Industry Research Jul , Infectious Diseases Townes, John GINFD0024B 07/01/08 Thru Oregon Dept of Human Svcs, Hlth Svcs Div fr DHHS 06/30/09 CDCP Emerging Infections Studies: Methicilling-resistant Stapylococcus aureus Study Federal Research Mar-09 9, Infectious Diseases Townes, John GINFD0024B 07/01/08 Thru Oregon Dept of Human Svcs, Hlth Svcs Div fr DHHS 06/30/09 CDCP Emerging Infections Studies: Methicilling-resistant Stapylococcus aureus Study Federal Research Sep-08 3, Thru ODHS Hlth Div, Infectious Diseases Townes, John GINFD0033A 11/20/08 Ctr for Disease Prevent & Epidem fr 06/30/10 DHHS CDCP Seroprevalence of Taenia Solium Taeniasis Among Household Contacts of Neurocysticercosis Cases Federal OSA Nov-08 20, Nephrology & Hypertension Anderson, Sharon GNEPH0089C 08/01/08 07/31/09 Kid Diseases Nephrology Training Grant Federal Research Jul , Nephrology & Hypertension Anderson, Sharon GNEPH0116A 02/01/09 01/31/10 Kid Diseases Novel Estorgen Metabolites and Experimental Polycystic Kidney Disease Federal Research Mar , Nephrology & Hypertension Bagby, Susan GNEPH0115A 07/01/08 Washington fr Fred Hutchinson Cancer 06/30/09 Rsch Ctr Biomarkers of fetal orgins of adult disease Private Research Feb-09 22, Nephrology & Hypertension Cohen, David GNEPH0104B 02/01/09 01/31/10 on Aging Genetic Determinants of Water Balance in the Elderly Federal Research Jun , Nephrology & Hypertension Ellison, David GNEPH0113A 09/15/08 08/31/09 Kid Diseases Advances in Renal Research: Human Diseases of Protein Processing Federal OSA Sep-08 12, The American Society Nephrology & Hypertension Ellison, David GNEPH0117A 01/01/09 12/31/09 of Nephrology Regulation of Thiazide-sensitive Transport Private Research Mar , The American Society Nephrology & Hypertension Ellison, David GNEPH0118A 01/01/09 12/31/09 of Nephrology Regulation of Thiazide-sensitive Transport Private Research May ,000.00

11 Nephrology & Hypertension Ellison, David GNEPH0118A 01/01/09 The American Society 01/01/09 of Nephrology Regulation of Thiazide-sensitive Transport Private Research Jun-09 (100,000.00) Nephrology & Hypertension Komers, Radko GNEPH0103B 03/01/09 Juvenile Diabetes 02/28/10 Rsch Fnd InterNatl Rho GTPases in Diabetic Nephropathy Private Research Feb , Nephrology & Hypertension Mayinger, Peter GNEPH0080E 06/01/09 of General Medical 06/30/10 Science Characterization of Sac1 Lipid Phosphatases Federal Research Jun , Nephrology & Hypertension McCormick, James GNEPH0105B 03/01/09 02/28/10 Kid Diseases Analysis of distal convoluted tubule function in vivo Federal Research Apr , Nephrology & Hypertension Norman, Douglas GNEPH /01/02 Thru Rhode Island Hospital fr DHHS NIH Natl Inst of Diab & Digest & Kid 01/31/08 Diseases A Randomized, Controlled Trial of Homocysteine (FAVORIT) Federal Research Jul-08 5, Nephrology & Hypertension Norman, Douglas GNEPH /01/02 Thru Rhode Island Hospital fr DHHS NIH Natl Inst of Diab & Digest & Kid 01/31/08 Diseases A Randomized, Controlled Trial of Homocysteine (FAVORIT) Federal Research Sep-08 10, Nephrology & Hypertension Norman, Douglas GNEPH0043B 02/01/08 Thru Rhode Island Hospital fr DHHS NIH Natl Inst of Diab & Digest & Kid 01/31/09 Diseases A Randomized, Controlled Trial of Homocysteine (FAVORIT) Federal Research Mar-09 22, Nephrology & Hypertension Norman, Douglas GNEPH0043B 02/01/08 Thru Rhode Island Hospital fr DHHS NIH Natl Inst of Diab & Digest & Kid 01/31/09 Diseases A Randomized, Controlled Trial of Homocysteine (FAVORIT) Federal Research Mar-09 29, Nephrology & Hypertension Norman, Douglas GNEPH0043C 02/01/09 Thru Rhode Island Hospital fr DHHS NIH Natl Inst of Diab & Digest & Kid 01/31/10 Diseases A Randomized, Controlled Trial of Homocysteine (FAVORIT) Federal Research Jun-09 50, California, San Francisco fr DHHS NIH Natl Inst of Allergy & Infectious Nephrology & Hypertension Norman, Douglas GNEPH0051B 10/01/07 04/30/10 Disease Immune Tolerance Network Clinical Trials Oversight Federal Research Apr-09 52, Nephrology & Hypertension Norman, Douglas GNEPH0051B 10/01/07 California, San Francisco fr DHHS NIH Natl Inst of Allergy & Infectious 04/30/09 Disease Immune Tolerance Network Clinical Trials Oversight Federal Research Jul-08 51, Nephrology & Hypertension Norman, Douglas GNEPH0064A 09/01/03 Thru Tufts University fr 05/31/09 Kid Diseases Renal transplantation, Homocysteine Lowering & Cognition Federal Research Dec Nephrology & Hypertension Norman, Douglas GNEPH0064A 09/01/03 Thru Tufts University fr 05/31/09 Kid Diseases Renal transplantation, Homocysteine Lowering & Cognition Federal Research Mar-09 2, Nephrology & Hypertension Obhrai, Jagdeep GNEPH0114A 08/01/08 11/30/08 Disease Activation of the alloimmune response Federal Research Feb-09 34, Nephrology & Hypertension Obhrai, Jagdeep GNEPH0114B 12/01/08 11/30/09 Disease Activation of the alloimmune response Federal Research Feb-09 92, Nephrology & Hypertension Rao, Maya GNEPH0112A 07/01/08 06/30/09 Natl Kidney Fnd The Management of Chronic Kidney DIsease by Primary Care Practitioners in Oregon Private Research Feb-09 50,000.00

12 Pulmonary & Critical Care Medicine Barker, Alan GPULM0118A 04/01/08 Behavioral Health 03/31/09 Systems Research Development and Cognitive Evaluation of the Quality of Life Quetionnaire in Bronchiectasis (QOL-B) Private Research Sep Pulmonary & Critical Care Medicine Barker, Alan GPULM /30/09 03/31/12 Gilead Sciences, Inc OL, MC Trial to Validate QOL Questionnaire- Bronchiectasis & Evaluate Perception of Symptom Improvement Following 1 Course of Aztreonam for Inhalation Solution in Subjects w/bronchiectasis & Gramnegative Bacteria in Airways Industry Research Mar , Pulmonary & Critical Care Medicine Buels, Kalmia GPULM0125A 07/01/08 N. L. Tartar Trust 06/30/09 Rsch Fellowship Determining the role of CCR3 in airway nerve function Private Research Jul-08 2, Pulmonary & Critical Care Medicine Buist, A GPULM0078C 06/01/07 Thru Kaiser Fnd Hospitals fr Bold Pharmaceutical 12/31/09 Consortium Burden of Obstruction Lung Disease - BOLD Phase III Industry Research Mar-09 19, Pulmonary & Critical Care Medicine Buist, A Sonia GPULM0078C 01/01/08 Thru Kaiser Fnd Hospitals fr Bold Pharmaceutical 12/31/08 Consortium Burden of Obstruction Lung Disease - BOLD Phase III Industry Research Oct-08 71, U.S. Dept of Veterans Surveillance of Medical Device Related Problems in Pulmonary & Critical Care Medicine Chesnutt, Mark GPULM0135A 07/01/09 10/15/09 Affairs Intensive Care Units Federal Research Jun-09 15, Pulmonary & Critical Care Medicine Fryer, Allison GPHYP0128C 12/01/08 11/30/09 of Environmental Hlth Asthma Exacerbation by Organophosphate Pesticides Federal Research Dec , Pulmonary & Critical Care Medicine Fryer, Allison GPHYP0128C 12/01/08 11/30/09 of Environmental Hlth Asthma Exacerbation by Organophosphate Pesticides Federal Research Mar-09 33, Role of Macrophage Costimualtory Molecules in Pulmonary & Critical Care Medicine Gold, Jeffrey GPULM0102C 01/01/09 12/31/09 Disease Polymicrobial Sepsis Federal Research Nov , Role of Macrophage Costimualtory Molecules in Pulmonary & Critical Care Medicine Gold, Jeffrey GPULM0102C 01/01/09 12/31/09 Disease Polymicrobial Sepsis Federal Research Jun-09 37, Pulmonary & Critical Care Medicine Gold, Jeffrey GPULM0111B 02/01/09 Thru 13Therapeutics, Inc. fr Inst of Allergy & 01/31/10 Infectious Disease Bacterial Induced Sepsis: A New Treatment Strategy Federal Research Apr-09 44, Pulmonary & Critical Care Medicine Gold, Jeffrey GPULM0127A 07/01/08 06/30/09 Cystic Fibrosis Fnd Program for Adult Care Excellence (PACE) Private Research Jul-08 27, Pulmonary & Critical Care Medicine Gold, Jeffrey GPULM0127B 07/01/09 06/30/10 Cystic Fibrosis Fnd Program for Adult Care Excellence (PACE) Private Research Jun-09 27, Thru Nabi A Phase 2, MC, Randomized, DB, PC study to Assess Safety & Immunogenicity of 2 Doses of 3'- Biopharmaceuticals fr aminomethylnicotine-p.aeruginosa i ti i r-exoprotein A Pulmonary & Critical Care Medicine Gonzales, David GPULM0091A 05/03/06 DHHS National 05/02/09 Institutes of Health Conjugate Vaccine in 2 Different Dosing Schedules in Smokers Who Want to Quit Federal Research Sep-08 6, Thru Nabi A Phase 2, MC, Randomized, DB, PC study to Assess Safety & Immunogenicity of 2 Doses of 3'- Biopharmaceuticals fr aminomethylnicotine-p.aeruginosa r-exoprotein A Pulmonary & Critical Care Medicine Gonzales, David GPULM0091A 05/03/06 DHHS National 05/02/09 Institutes of Health Conjugate Vaccine in 2 Different Dosing Schedules in Smokers Who Want to Quit Federal Research Dec-08 5, Pulmonary & Critical Care Medicine Hagg, Daniel GPULM /09/08 Lilly Research 10/31/11 Laboratories Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock Industry Research Oct-08 70, Pulmonary & Critical Care Medicine Hall, Stephen GPULM0110C 07/01/09 06/30/10 Blood Inst Interfacial Adsorption of Pulmonary Surfactant Federal Research Jun , Pulmonary & Critical Care Medicine Hall, Stephen GPULM0123B 07/01/09 06/30/10 Blood Inst Interfacial Phase Behavior of Pulmonary Surfactant Federal Research Jun , Pulmonary & Critical Care Medicine Jacoby, David GPULM0107C 05/01/09 04/30/10 Blood Inst Mechanisms of Virus-Induced Hyperreactivity in Atopics Federal Research Jun , Pulmonary & Critical Care Medicine Jacoby, David GPULM0117B 04/01/09 03/31/10 Blood Inst Multidisciplinary Research Training in Pulmonary Medicine Federal Research Apr , Pulmonary & Critical Care Medicine Jacoby, David GPULM0120B 07/01/09 06/30/10 Disease Airway Eosinophil Activation by Anticholinergic Therapy Federal Research Jun ,500.00

13 Pulmonary & Critical Care Medicine Jacoby, David GPULM0126A 01/01/08 GlaxoSmithKline 12/31/08 Services Unlimited N. L. Tartar Trust Pulmonary & Critical Care Medicine Kaufman, Elad GPULM0128A 07/01/08 06/30/09 Oxford Immunotec Pulmonary & Critical Care Medicine Lewinsohn, David GCAEI0211A1 09/01/08 08/31/09 of Allergy & Inf Dis Pulmonary & Critical Care Medicine Lewinsohn, David GPULM0070A 09/30/04 09/29/09 CONTRACT Melinda Gates Pulmonary & Critical Care Medicine Lewinsohn, David GPULM /01/09 06/30/12 Foundation Effect of GSK233705B on eosinophil activation and vagally mediated hyperreactivity in the antigen challenged guinea pig Industry OSA Jul-08 99, Rsch Fellowship Involvement of TLR7 in neuronal detection of virus Private Research Aug-08 2, Limited IGRA evaluation in Nontuberculous Mycobacteria Disease Industry Research Sep-08 12, Large Scale Antibody and T Cell Epitope Discovery Program Federal Research Aug , Recognition of Mtb-infected Cells by CD8+ T Pulmonary & Critical Care Medicine Lewinsohn, David GPULM0101C 01/01/09 12/31/09 Disease Lymphocytes Federal Research Jun-09 30, Recognition of Mtb-infected Cells by CD8+ T Pulmonary & Critical Care Medicine Lewinsohn, David GPULM0101C 01/01/09 12/31/09 Disease Lymphocytes Federal Research Nov , U.S. Dept of Veterans Pulmonary & Critical Care Medicine Lewinsohn, David GPULM0129A 07/01/08 06/30/10 Affairs VA IPA for Melanie Hariff Federal Research Aug-08 97, Oxford Immunotec Pulmonary & Critical Care Medicine Lewinsohn, David GPULM0130A 08/25/08 02/24/09 Limited Using the CD8 T cell response to Improve T.SPOT-TB Industry Research Sep-08 13, U.S. Dept of Veterans IPA for Sue Smyk-Pearson HLA-E Dependent Pulmonary & Critical Care Medicine Lewinsohn, David GPULM0132A 12/01/08 11/30/10 Affairs Recognition of Mtb-infected Cells by CD8+Lymphocytes Federal Research Jan-09 49, A Phase I, Double-Blind, Randomized, Placebo-controlled Thru Aeras Global TB Leukapheresis Study to Obtain Lymphocytes for Study of Vaccine Fnd fr Bill & Pulmonary & Critical Care Medicine Linch, Stefanie GPULM0136A 07/01/09 06/30/10 N. L. Tartar Trust N. L. Tartar Trust Pulmonary & Critical Care Medicine Manzer, Stefanie GPULM0124A 07/01/08 06/30/09 Rsch Fellowship Immune Responses in Healthy Adult Volunteers in the U.S.who receive BCG Vaccination followed by Boosting w/aeras-402 Private Research Jun-09 95, The Role of IL-5 and Eosinophils in the Innate Immune Response to Sepsis Private Research Jun-09 2, The role of eosinophils and IL-5 the innate immune response to sepsis Private Research Jul-08 2, Organophosphates Modify Eosinophil and Nerve Pulmonary & Critical Care Medicine Proskocil, Becky GPHYP0118C 08/01/08 07/31/09 of Environmental Hlth Interaction Federal Research Jul-08 50, Pulmonary & Critical Care Medicine Smith, Stephen GPHYP0111D1 01/01/09 12/31/09 Blood Inst Presynaptic Mechanisms of Neurotransmission in NTS Federal Research Jan , Pulmonary & Critical Care Medicine Verhein, Kirsten GPULM0115B 01/01/09 Assoc., Pacific 12/31/09 Mountain Affiliate Inflammatory pathways that induce neural plasticity in heart and lung Private Research Dec-08 24, $ 30,456,971

Summary of Risk Minimization Measures

Summary of Risk Minimization Measures Table 6.1.4-1: Summary of Risk Minimization Measures Safety Concern Vaccination Hepatic and renal impairment Combination therapy Elderly Routine Risk Minimization Measures Specific subsection on vaccination

More information

Peking University People's Hospital, Peking University Institute of Hematology

Peking University People's Hospital, Peking University Institute of Hematology Qian Jiang, M.D. Peking University People's Hospital, Peking University Institute of Hematology No. 11 Xizhimen South Street, Beijing, 100044, China. Phone number: 86-10-66583802 Mobile: 86-13611115100

More information

Pfizer Independent Grants for Learning & Change Track 2- Annual Meetings: Submission Deadlines, Areas of Interest & Educational Goals

Pfizer Independent Grants for Learning & Change Track 2- Annual Meetings: Submission Deadlines, Areas of Interest & Educational Goals In order to submit a request for general meeting support through Track 2- Annual Meetings the answer to the following questions must be Yes : Does the activity align with Pfizer s areas of interest? (listed

More information

SYNOPSIS. Clinical Study Report IM Double-blind Period

SYNOPSIS. Clinical Study Report IM Double-blind Period Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Abatacept () Name of Active Ingredient: Abatacept () Individual Study Table Referring to the Dossier SYNOPSIS (For National Authority

More information

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: June 25, ClinicalTrials.gov ID: NCT

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: June 25, ClinicalTrials.gov ID: NCT ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: June 25, 2014 ClinicalTrials.gov ID: NCT00372385 Study Identification Unique Protocol ID: VX05-950-104EU Brief Title:

More information

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD CLINICAL OFFICES Digestive Health Liver Clinic 900 Blake Wilbur Dr MC 5355 Palo Alto, CA 94304 Tel (650) 498-7999 Fax (650) 724-9454 Liver Transplant Clinic 300 Pasteur Dr A160 Bio MC 5309 Stanford, CA

More information

Infergen (interferon alfacon-1) with Ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab, ribavirin tablets/capsules - all strengths)

Infergen (interferon alfacon-1) with Ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab, ribavirin tablets/capsules - all strengths) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.03.04 Subject: Infergen with Ribavirin Page: 1 of 8 Last Review Date: March 13, 2014 Infergen with Ribavirin

More information

Information contained in this listing is collected and maintained by the American Board of Internal Medicine.

Information contained in this listing is collected and maintained by the American Board of Internal Medicine. 1936-1940 1936 1937 1938 1939 1940 Decade Internal Medicine 27 209 90 227 255 808 1941-1950 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 Decade Internal Medicine 242 204 342 271 314 473 654 486 335

More information

AHRQ Effective Health Care Program Clinical and Comparative Effectiveness Research Methods: II

AHRQ Effective Health Care Program Clinical and Comparative Effectiveness Research Methods: II AHRQ Effective Health Care Program Clinical and Comparative Effectiveness Research Methods: II June 1-2, 2009 John M. Eisenberg Building Agency for Healthcare Research and Quality AHRQ Conference Center

More information

CENTER FOR CLINICAL TRIALS St. Luke s Medical Center. Ongoing Clinical Trials DEPARTMENT OF MEDICINE (24)

CENTER FOR CLINICAL TRIALS St. Luke s Medical Center. Ongoing Clinical Trials DEPARTMENT OF MEDICINE (24) CENTER FOR CLINICAL TRIALS St. Luke s Medical Center Ongoing Clinical Trials DEPARTMENT OF MEDICINE (24) Arthritis TITLE : A Randomized, Double Blind, Parallel-Group Study Of Cardiovascular Safety In Osteoarthritis

More information

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL)

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL) OCHSNER PHYSICIAN PARTNERS PQRS Measures by Specialty (FINAL) Allergy and Immunology 2. Asthma: Pharmacologic Therapy for Persistent Asthma - Ambulatory Care Setting (PQRS 53) 3. Patients aged 18 years

More information

eltrombopag (Promacta )

eltrombopag (Promacta ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

HEALTH MATTERS, INC. SUMMARY OF PROJECTS AND KEY ACCOMPLISHMENTS TO 2016

HEALTH MATTERS, INC. SUMMARY OF PROJECTS AND KEY ACCOMPLISHMENTS TO 2016 Selected 2016 Highlights Epidemiologic research on chronic kidney disease and fistula patency, solid and hematologic malignancies Health economics and outcomes research on beta3-agonist treatment for overactive

More information

Genentech Research & Early Development

Genentech Research & Early Development Genentech Research & Early Development Founders Research Centers 1 & 2 Founders Research Centers 1 & 2 Andrew Chan, M.D., Ph.D. Senior Vice President, Research Biology September 2017 gred focus areas Discovering

More information

Summary of Strategic Competitive Analysis and Publication Planning

Summary of Strategic Competitive Analysis and Publication Planning Summary of Strategic Competitive Analysis and Publication Planning Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Briefing

More information

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of:

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 8 Last Review Date: March 17, 2017 Simponi / Simponi

More information

Pegasys Ribavirin

Pegasys Ribavirin Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.08 Subsection: Anti-infective Agents Original Policy Date: January 1, 2006 Subject: Pegasys Ribavirin

More information

Internal Medicine Certification Examination Blueprint

Internal Medicine Certification Examination Blueprint Internal Medicine Certification Examination Blueprint What Does the Examination Cover? The exam is designed to evaluate the extent of the candidate s knowledge and clinical judgment in the areas in which

More information

Infergen Monotherapy. Infergen (interferon alfacon-1) Description

Infergen Monotherapy. Infergen (interferon alfacon-1) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.03.03 Subject: Infergen Monotherapy Page: 1 of 7 Last Review Date: March 13, 2014 Infergen Monotherapy

More information

Summary of late stage clinical trials. As of Jul. 22, 2016

Summary of late stage clinical trials. As of Jul. 22, 2016 Summary of late stage clinical trials As of Jul. 22, 2016 List of abbreviations AE BID DLT GFR iv MTD ORR OS PD PFS PK po PPK Q2W Q3W Q4W QD QW sc TID Adverse Events Twice daily Dose Limiting Toxicity

More information

Clinical Trial List

Clinical Trial List Clinical Trial List 2005 2008 Service Driven. Quality Focused. Global Perspective. Clinical Trial List 2005-2008 1 Pharmacokinetic A Two-Period, Single Dose Pharmacokinetic Study of Three Sustained-Release

More information

HMO: Medical (provider setting); Rx (out patient) PPO/CDHP: Rx

HMO: Medical (provider setting); Rx (out patient) PPO/CDHP: Rx BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Epogen, Procrit (epoetin alfa, injection) Commercial HMO/PPO/CDHP

More information

PEDIATRICS. THE POWER OFx. Experts. Experienc e. Execution. Conducting Pediatric Studies Presents Great Challenges. Experts: Experience: Execution:

PEDIATRICS. THE POWER OFx. Experts. Experienc e. Execution. Conducting Pediatric Studies Presents Great Challenges. Experts: Experience: Execution: THE POWER OFx Experts. Experienc e. Execution. Medpace combines expertise, experience and execution for a winning combination in pediatric studies Experts: Key pediatricians on staff who are trained in

More information

ENROLLMENT : Line of Business Summary

ENROLLMENT : Line of Business Summary ENROLLMENT : Line of Business Summary Date Range : JAN 2017 through DEC 2017 COMPREHENSIVE MAJOR MEDICAL Print Date : 1/19/2018 9:43:49AM Page 1 of 1 Month Year Single 2 Person : Emp/Spouse 2 Person :

More information

ASSAYS UTILZIED TO MONITOR HCV AND ITS TREATMENT

ASSAYS UTILZIED TO MONITOR HCV AND ITS TREATMENT ASSAYS UTILZIED TO MONITOR HCV AND ITS TREATMENT Mitchell L Shiffman, MD Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, VA Liver Institute of Virginia Education, Research

More information

Actemra (tocilizumab) CG-DRUG-81

Actemra (tocilizumab) CG-DRUG-81 Market DC Actemra (tocilizumab) CG-DRUG-81 Override(s) Prior Authorization Approval Duration 1 year Medications Line of Business Quantity Limit Actemra (tocilizumab) vials VA MCD and All L-AGP May be subject

More information

Description of Commitment

Description of Commitment AbbVie U.S. Postmarketing s Table: Name of ANDROGEL (testosterone gel) CREON (pancrelipase) CREON (pancrelipase) / 022309 and 021015 20725 20725 125057/0 125057/114 Description of A randomized, double-blind,

More information

ASSESSMENT PRIOR TO TREATMENT DO WE NEED IL28B TESTING?

ASSESSMENT PRIOR TO TREATMENT DO WE NEED IL28B TESTING? ASSESSMENT PRIOR TO TREATMENT DO WE NEED IL28B TESTING? DO WE NEED LIVER BIOPSY? Mitchell L Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, VA POTENTIAL

More information

RARE DISEASE. THE POWER OFx. Experts. Experienc e. Execution. Challenges Conducting Rare Disease Studies. Experts: Experience: Execution:

RARE DISEASE. THE POWER OFx. Experts. Experienc e. Execution. Challenges Conducting Rare Disease Studies. Experts: Experience: Execution: THE POWER OFx TM Experts. Experienc e. Execution. The Power of X in Rare Disease Experts: Committed cross-functional team of Rare Disease experts comprised of doctors, project managers, regulatory consultants,

More information

Olumiant (baricitinib) NEW PRODUCT SLIDESHOW

Olumiant (baricitinib) NEW PRODUCT SLIDESHOW Olumiant (baricitinib) NEW PRODUCT SLIDESHOW Introduction Brand name: Olumiant Generic name: Baricitinib Pharmacological class: Janus kinase (JAK) inhibitor Strength and Formulation: 2mg; tabs Manufacturer:

More information

Hepatitis C Management and Treatment

Hepatitis C Management and Treatment Hepatitis C Management and Treatment Kaya Süer Near East University Faculty of Medicine Infectious Diseases and Clinical Microbiology 1 Discovery of Hepatitis C Key facts Hepatitis C: the virus can cause

More information

Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus

Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus JEFFREY NADELSON MD, ALAN EPSTEIN MD, THOMAS SEPE MD BOSTON UNIVERSITY SCHOOL OF MEDICINE ROGER WILLIAMS MEDICAL

More information

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036 Marc Moss, MD President, American Thoracic Society Nmoore@thoracic.org; (202) 296. 9770 1150 18 th St, N.W. #300 Washington, DC 20036 STATEMENT OF THE AMERICAN THORACIC SOCIETY SUBMITTED TO THE HOUSE LABOR,

More information

The Pennine Acute Hospitals NHS Trust Performance in delivering clinical research Reporting period 1 October 2017 to 30 September 2018

The Pennine Acute Hospitals NHS Trust Performance in delivering clinical research Reporting period 1 October 2017 to 30 September 2018 The Pennine Acute Hospitals NHS Trust Performance in delivering clinical research Reporting period 1 October 2017 to 30 September 2018 REC reference IRAS reference Name of trial Target number of? Minimum

More information

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.01 Subject: Intron A Hepatitis B Page: 1 of 7 Last Review Date: November 30, 2018 Intron A Hepatitis

More information

Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X

Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X Primary Prevention Breast Cancer Prevention Member: Mammography reminder letters to female members ages 51.5-74 who are overdue to get a mammogram Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Providers:

More information

Episodes of Care Risk Adjustment

Episodes of Care Risk Adjustment Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous

More information

Dengue: A disease burden in Sri Lanka A Complex Phase III Vaccine Trial

Dengue: A disease burden in Sri Lanka A Complex Phase III Vaccine Trial Dengue: A disease burden in Sri Lanka A Complex Phase III Vaccine Trial Country Overview Size: 65,610 sq km Population: 21,324,791 Population growth rate: 0.904% Population: Not genetically homogeneous

More information

PROFESSIONAL MEMBERSHIPS

PROFESSIONAL MEMBERSHIPS June 2012 January 2014 October 2009 May 2012 Staff Rheumatologist, Diagnostic Clinic, Clearwater, FL Staff Rheumatologist, Arthritis Associates, Palm Harbor, FL 2008 2012 Co-Investigator, Arthritis Research

More information

What prescribers need to know

What prescribers need to know HUMIRA Citrate-free presentations in an Electronic Medical Record (EMR) What prescribers need to know 2 / This is your guide to identifying HUMIRA Citrate-free presentations in your Electronic Medical

More information

The Impact of Research on the Care of Addicted Patients. Update. Nora D. Volkow, M.D. Director National Institute on Drug Abuse

The Impact of Research on the Care of Addicted Patients. Update. Nora D. Volkow, M.D. Director National Institute on Drug Abuse The Impact of Research on the Care of Addicted Patients A Update Nora D. Volkow, M.D. Director National Institute on Drug Abuse HISTORY - previous history - expectation - learning DRUGS BIOLOGY - genetics

More information

PHO: Metadata for Mortality from Avoidable Causes

PHO: Metadata for Mortality from Avoidable Causes Snapshots @ PHO: Metadata for Mortality from Avoidable Causes This indicator captures individuals under 75 years of age who have died with a condition considered as avoidable recorded as the primary cause

More information

Tuberculosis and Biologic Therapies: Risk and Prevention

Tuberculosis and Biologic Therapies: Risk and Prevention Tuberculosis and Biologic Therapies: Risk and Prevention Kevin L. Winthrop, MD, MPH Associate Professor, Divisions of Infectious Diseases, Public Health and Preventive Medicine Oregon Health & Science

More information

Simponi / Simponi ARIA (golimumab)

Simponi / Simponi ARIA (golimumab) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 6 Last Review Date: September 15, 2016 Simponi / Simponi

More information

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017 Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017 Conflicts of interest Receive

More information

CCR Keywords Primary keywords

CCR Keywords Primary keywords CCR Keywords Primary keywords 1 Aboriginal health 2 Administration and health services 3 Allied health 4 Anaesthesia and intensive care 5 Biochemistry 6 Cardiology and cardiac surgery 7 Complementary medicine

More information

Current Treatments for HCV

Current Treatments for HCV Current Treatments for HCV Mitchell L. Shiffman, MD, FACG Advisory Committee/Board Member: Achillion, Anadys, Boehringer-Ingelheim, BMS, Conatus, Genentech, Gen-Probe, Gilead, Globeimmune, GSK, Janssen,

More information

2015 PQRS Registry. Source Measure Title Measure Description CITIUS1

2015 PQRS Registry. Source Measure Title Measure Description CITIUS1 1 CQ-IQ covers 65 CMS defined measures that Eligible Providers (EPs) have to report on to assess quality of care provided to the patients. Version Supported: PQRS Registry 2015 65 measures Reporting Period:

More information

Orencia (abatacept) DRUG.00040

Orencia (abatacept) DRUG.00040 Market DC Orencia (abatacept) DRUG.00040 Override(s) Prior Authorization Quantity Limit Approval Duration 1 year Medications Comments Quantity Limit Orencia (abatacept) - AGP, VA MCD only 4 vials per 28

More information

Curriculum Vitae, Joseph J. Savon, M.D.

Curriculum Vitae, Joseph J. Savon, M.D. CONTACT INFORMATION: Joseph J. Savon, M.D. Hassman Research Institute, LLC. 175 Cross Keys Road Centennial Center, Bldg. 300 B Berlin, NJ 08009 Site Selection and Information: Bobbie Theodore, Alliance

More information

Case Study: Physician and Patient-Facing Medical Education APPs. Sandeep Pulim, MD Chief Medical Information Officer

Case Study: Physician and Patient-Facing Medical Education APPs. Sandeep Pulim, MD Chief Medical Information Officer Case Study: Physician and Patient-Facing Medical Education APPs Sandeep Pulim, MD Chief Medical Information Officer Quality IME Collaborating for Patient Care Commercial Supporter Medical Education Provider

More information

Mrs. Isabelle GAUDIN 22 years experience in Clinical Research LEAD CRA / SENIOR CLINICAL RESEARCH ASSOCIATE

Mrs. Isabelle GAUDIN 22 years experience in Clinical Research LEAD CRA / SENIOR CLINICAL RESEARCH ASSOCIATE Sté Aid ARC 36, Comba dels Martirs 11570 PALAJA FRANCE Fax : +33 4 68 47 03 52 Mob : +33 6 14 68 71 71 E-mail : isabelle.gaudin@aidarc.com Mrs. Isabelle GAUDIN 22 years experience in Clinical Research

More information

The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not

The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

PEDIATRICS. THE POWER OFx. Experts. Experienc e. Execution. Conducting Pediatric Studies Presents Great Challenges. Experts: Experience: Execution:

PEDIATRICS. THE POWER OFx. Experts. Experienc e. Execution. Conducting Pediatric Studies Presents Great Challenges. Experts: Experience: Execution: THE POWER OFx Experts. Experienc e. Execution. Medpace combines expertise, experience and execution for a winning combination in pediatric studies Experts: Five key pediatricians on staff who are trained

More information

Paediatric Pulmonology Report 2014

Paediatric Pulmonology Report 2014 Paediatric Pulmonology Report 2014 STATS Out-Patients 1864 visits ASTHMA BRONCHIE CYSTIC FIBROSIS JANUARY 72 12 16 FEBRUARY 118 37 20 MARCH 139 36 16 APRIL 89 26 24 MAY 122 31 15 JUNE 114 25 10 JULY 155

More information

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi Joseph T. DiPiro, PharmD, FCCP Panoz Professor of Pharmacy, College

More information

Fat Grafting: Research Aspects

Fat Grafting: Research Aspects Fat Grafting: Research Aspects P A U L C E D E R N A, M D P L A S T I C S U R G E R Y F O U N D A T I O N P R E S I D E N T - E L E C T C H I E F, S E C T I O N O F P L A S T I C S U R G E R Y R O B E

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Activated partial thromboplastin time abnormality, perioperative approach to, 104 105 Acute kidney injury, perioperative, 89 99 early

More information

Domestic. Domestic. Domestic. Domestic. Seoul. Domestic. Domestic. Domestic. Domestic

Domestic. Domestic. Domestic. Domestic. Seoul. Domestic. Domestic. Domestic. Domestic Degree and Field of Study (2016): Clinical Effectiveness Practice Organization Type of Organization or Harvard Pilgrim Healthcare Institute Harvard T.H. Chan School of Public Health Seoul National University

More information

USMLE STEP 2 CK REVIEW STUDY GUIDE

USMLE STEP 2 CK REVIEW STUDY GUIDE USMLE STEP 2 CK REVIEW STUDY GUIDE 2014 edition Brian Jenkins, MD Although you have the flexibility to view the videos in any order, we strongly recommend that you watch the videos in the order in which

More information

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn Letter Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, openlabel study J. Rosenstock 1,2,

More information

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.51 Subject: Simponi / Simponi ARIA Page: 1 of 9 Last Review Date: March 16, 2018 Simponi / Simponi

More information

Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis

Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and

More information

Pfizer Global Medical Grants Annual Meetings: Submission Deadlines, Primary Areas of Interest, & Educational Goals

Pfizer Global Medical Grants Annual Meetings: Submission Deadlines, Primary Areas of Interest, & Educational Goals In order to submit a request for general meeting support for an Annual Meeting, the answers to the following questions must be Yes : Does the activity align with Pfizer s Primary Areas of Interest? (listed

More information

RECOMMENDED COURSE ORDER

RECOMMENDED COURSE ORDER Although you have the flexibility to view the videos in any order, we strongly recommend that you watch the videos in the order in which your dashboard presents them regardless of how many videos you view

More information

Early Career Investigator Awards. 84 Lipid and Lipoprotein Metabolism: Clinical Lifestyle & Behavioral Medicine

Early Career Investigator Awards. 84 Lipid and Lipoprotein Metabolism: Clinical Lifestyle & Behavioral Medicine AHA Scientific Sessions Awards and Travel Grants Available by Abstract Category and Award applicants must have submitted an abstract to a category listed under that award and be a member of award s the

More information

A P P O I N T M E N T S AND P R O M O T I O NS

A P P O I N T M E N T S AND P R O M O T I O NS A P P O I N T M E N T S AND P R O M O T I O NS Appointed Emeritus Professor of Medicine: W. Lowell Maughan, MD, Cardiology Promotion to Professor of Medicine: Paul D. Auwaerter, MD, Infectious Diseases

More information

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Co-morbidities in Substance Abuse that Impact Managing TB Lisa Armitige, MD, PhD April 27, 2011 Lisa Armitige, MD, PhD has the following

More information

ARRHYTHMIAS AND DEVICE THERAPY

ARRHYTHMIAS AND DEVICE THERAPY Topic List A BASICS 1 History of Cardiology 2 Clinical Skills 2.1 History Taking 2.2 Physical Examination 2.3 Electrocardiography 2.99 Clinical Skills - Other B IMAGING 3 Imaging 3.1 Echocardiography 3.2

More information

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust NHS Nurses Update June 2010 Chronic Hepatitis HBV / HCV David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology

More information

Abatacept (Orencia) for active rheumatoid arthritis. August 2009

Abatacept (Orencia) for active rheumatoid arthritis. August 2009 Abatacept (Orencia) for active rheumatoid arthritis August 2009 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to

More information

Drug Regulatory Affairs. Lyxumia. Summary of the Risk Management Plan (RMP) for Lyxumia (lixisenatide)

Drug Regulatory Affairs. Lyxumia. Summary of the Risk Management Plan (RMP) for Lyxumia (lixisenatide) Drug Regulatory Affairs Lyxumia Summary of the Risk Management Plan (RMP) for Lyxumia (lixisenatide) Document version: 02 Document date: 08-Mar-2018 1 Summary of the risk management plan (RMP) for Lyxumia

More information

September 14, Attached is the original press release made by BMS for your information.

September 14, Attached is the original press release made by BMS for your information. September 14, 2016 European Commission Approves Bristol-Myers Squibb s ORENCIA (abatacept) for the Treatment of Highly Active and Progressive Disease in Adult Patients with Rheumatoid Arthritis Not Previously

More information

Attracting Talent & Driving Growth in Wisconsin

Attracting Talent & Driving Growth in Wisconsin Attracting Talent & Driving Growth in Wisconsin v 2 nd Annual Future Wisconsin Economic Summit Kevin Conroy, Chairman & CEO December 9, 2015 WMC Foundation: Second Annual Future Wisconsin Economic Summit

More information

CURRICULUM VITAE ANWAR SHAFI, MD

CURRICULUM VITAE ANWAR SHAFI, MD CURRICULUM VITAE ANWAR SHAFI, MD Work Address Postal address Southern Illinois University School of Medicine P.O. Box l9658 Springfield, IL 62794-9658 E-Mail Address Present Position ashafi@siumed.edu

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Rituximab for the Treatment of Rheumatoid Arthritis File Name: Origination: Last CAP Review: Next CAP Review: Last Review: rituximab_for_the_treatment_of_rheumatoid_arthritis 4/2008

More information

PCORI s Hepatitis C Workshop. Arlington, VA October 17, 2014

PCORI s Hepatitis C Workshop. Arlington, VA October 17, 2014 PCORI s Hepatitis C Workshop Arlington, VA October 17, 2014 1 Plenary Session: Review and Discussion of Prioritized CER Questions Eric B. Bass, MD Director, Johns Hopkins Evidence-based Practice Center

More information

Positive Living Conference

Positive Living Conference Positive Living Conference Ft. Walton Beach, Thomas Liberti Chief, Bureau of HIV/AIDS Department of Health March 11, 2011 Tallahassee, 1 The Epidemic in, 2010 60% White Population: 18.8 million (4 th 16%

More information

PRELIMINARY RYAN WHITE HIV/AIDS PROGRAM CLINICAL CARE CONFERENCE AGENDA

PRELIMINARY RYAN WHITE HIV/AIDS PROGRAM CLINICAL CARE CONFERENCE AGENDA PRELIMINARY RYAN WHITE HIV/AIDS PROGRAM CLINICAL CARE CONFERENCE AGENDA 9:00 9:15 AM Welcome and Introductions TUESDAY, DECEMBER 15, 2015 9:00 AM 5:05 PM 9:15 9:45 AM Update on the Ryan White HIV/AIDS

More information

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Tuberculosis and Diabetes Mellitus Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Learning Objectives Understand the impact of uncontrolled diabetes mellitus (DM) on TB infection

More information

Monitoring hepatitis C treatment uptake in Australia

Monitoring hepatitis C treatment uptake in Australia Monitoring hepatitis C treatment uptake in Australia Issue #7 July 217 1 Initiations of new treatment for chronic hepatitis C in 216 An estimated 32,4 individuals initiated direct acting antiviral (DAA)

More information

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research Action to Cure Kidney Cancer 2016 Campaign to Fund Kidney Cancer Research Kidney Cancer Facts 9 th most common cancer in the U.S. Until recently, 3 rd highest rate of increasing incidence of all cancers

More information

CURRICULUM VITAE. RESEARCH SITE NAME/ ADDRESS: Main Office: EDUCATION/TRAINING: BOARD CERTIFIED: BOARD CERTIFIED/ELIGIBLE NAME: TITLE:

CURRICULUM VITAE. RESEARCH SITE NAME/ ADDRESS: Main Office: EDUCATION/TRAINING: BOARD CERTIFIED: BOARD CERTIFIED/ELIGIBLE NAME: TITLE: CURRICULUM VITAE SIGNATURE: NAME: TITLE: Roy C, Springer, MD Principal Investigator DATE: DATE UPDATED: April 2016 RESEARCH SITE NAME/ ADDRESS: Main Office: MD Strategies Research Centers 6280 Jackson

More information

PROGRAMME AT A GLANCE

PROGRAMME AT A GLANCE PROGRAMME AT A GLANCE Hotel Hyatt Andaz Hotel Pullman Date Hall-H1 Hall-H2 Hall-P1 Hall-P2 Hall-P3 Hall-P4 Hall-P5 Hall-P6 Basic science workshop 1 Basic Science Workshop 2 Postgraduate Course - Liver

More information

Pharmacotherapy Handbook

Pharmacotherapy Handbook Pharmacotherapy Handbook Eighth Edition Barbara G. Wells, PharmD, HP, FCCP, BCPP Dean and Professor Executive Director, Research Institute of Pharmaceutical Sciences School of Pharmacy, The University

More information

Internist Diagnosis and Management of Chronic Hepatitis B Virus Infection

Internist Diagnosis and Management of Chronic Hepatitis B Virus Infection UPDATE IN OFFICE MANAGEMENT Internist Diagnosis and Management of Chronic Hepatitis B Virus Infection Brian J. McMahon, MD, a Joan Block, RN, BSN, b Barbara Haber, MD, c Thomas London, MD, d James A. McHugh,

More information

Hepatitis C and Innovative Public Health Practice

Hepatitis C and Innovative Public Health Practice Hepatitis C and Innovative Public Health Practice Ann Thomas MD, MPH Ann Shindo, PhD, MSW, MPH, MS Oregon Public Health Division Prevalence of anti-hcv Prevalence of Anti-HCV* (US,1999 2002 NHANES**) Overall

More information

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.18 Subject: Orencia Page: 1 of 6 Last Review Date: December 8, 2017 Orencia Description Orencia (abatacept)

More information

Curriculum Vitae, Anand Mehta, M.D. Anand Mehta, M.D. Pacific Research Partners, LLC 1611 Telegraph Avenue, Suite 1550 Oakland, CA 94612

Curriculum Vitae, Anand Mehta, M.D. Anand Mehta, M.D. Pacific Research Partners, LLC 1611 Telegraph Avenue, Suite 1550 Oakland, CA 94612 CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Site Liaison Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com AFFILIATIONS: Collaborative Neuroscience

More information

GENENTECH AND BIOGEN IDEC RECEIVE A COMPLETE RESPONSE FROM FDA FOR EARLIER USE OF RITUXAN FOR RHEUMATOID ARTHRITIS

GENENTECH AND BIOGEN IDEC RECEIVE A COMPLETE RESPONSE FROM FDA FOR EARLIER USE OF RITUXAN FOR RHEUMATOID ARTHRITIS NEWS RELEASE Genentech Contacts: Media / Advocacy: Megan Pace (650) 467-7334 Investor: Susan Morris (650) 225-6523 Karl Mahler 011 41 61 68785 03 Biogen Idec Contacts: Media: Amy Reilly (617) 914-6524

More information

The BlueCompare SM Physician Designation Program

The BlueCompare SM Physician Designation Program The BlueCompare SM Physician Designation Program Continuing escalation of health care costs has driven premiums and medical expenses to higher and higher levels each year, motivating employers and consumers

More information

Premium Specialty: Pediatrics

Premium Specialty: Pediatrics Premium Specialty: Pediatrics Credentialed Specialties include: Adolescent Medicine, Pediatric Adolescent, and Pediatrics This document is designed to be used in conjunction with the UnitedHealth Premium

More information

UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty

UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty UnitedHealth Premium Physician Designation Program Episode Treatment Groups (ETG ) Description and Specialty 666700 Acne Family Medicine, Internal Medicine, Pediatrics 438300 Acute Bronchitis Allergy,

More information

proposed set to a required subset of 3 to 5 measures based on the availability of electronic

proposed set to a required subset of 3 to 5 measures based on the availability of electronic CMS-0033-P 143 proposed set to a required subset of 3 to 5 measures based on the availability of electronic measure specifications and comments received. We propose to require for 2011 and 2012 that EP's

More information

Publication Plan 2017

Publication Plan 2017 Publication Plan 2017 A passion for turning high quality, independent research insights into actionable commercial intelligence. Why Spherix Global Insights? Our independent reports are designed, developed,

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

The paper provides an update for the Trust Board on hospital mortality and presents the updated Trust Mortality Action Plan.

The paper provides an update for the Trust Board on hospital mortality and presents the updated Trust Mortality Action Plan. ENC No 13 Meeting Trust Board Date 28 th November 2013 Title of Paper Lead Director Author Hospital Mortality Update Mr Amir Khan, Medical Director Mr Amir Khan, Medical Director PURPOSE OF THE PAPER The

More information

Preventive Health Guidelines

Preventive Health Guidelines Preventive Health Guidelines Guide to Clinical Preventive Services Adult LifeWise has adopted the United States Preventive Services Task Force (USPSTF) Guide to Clinical Preventive Services. The guideline

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 3041-8 Program Step Therapy Medications UnitedHealthcare Pharmacy Clinical Pharmacy Programs *Orencia (abatacept) *This step criteria refers to the subcutaneous formulation of abatacept

More information